FCPA Guide's Lessons For Life Sciences Companies

Law360, New York (December 14, 2012, 12:19 PM EST) -- The U.S. Chamber of Commerce “praised” the Foreign Corrupt Practices Act Guidance. The Chamber of Commerce did not get what it wanted but it had to recognize that the FCPA guidance was helpful for businesses. The FPCA guidance provides important information for compliance, due diligence and other relevant issues.

Some industries received a little bit of relief; others did not. Unfortunately, for the pharmaceutical and medical device industries, the FCPA guidance only confirmed what they already knew — they operate in a high-risk industry, in high-risk...
To view the full article, register now.